DNA vs. ARDX
Compare and contrast key facts about Ginkgo Bioworks Holdings, Inc. (DNA) and Ardelyx, Inc. (ARDX).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: DNA or ARDX.
Performance
DNA vs. ARDX - Performance Comparison
Returns By Period
In the year-to-date period, DNA achieves a -90.59% return, which is significantly lower than ARDX's -20.65% return.
DNA
-90.59%
-28.70%
-77.32%
-88.88%
N/A
N/A
ARDX
-20.65%
-16.33%
-37.08%
13.89%
-5.20%
-14.25%
Fundamentals
| DNA | ARDX | |
|---|---|---|
| Market Cap | $370.74M | $1.13B |
| EPS | -$12.89 | -$0.32 |
| Total Revenue (TTM) | $217.95M | $251.85M |
| Gross Profit (TTM) | $138.89M | $212.93M |
| EBITDA (TTM) | -$626.41M | -$53.06M |
Key characteristics
| DNA | ARDX | |
|---|---|---|
| Sharpe Ratio | -0.90 | 0.15 |
| Sortino Ratio | -2.34 | 0.83 |
| Omega Ratio | 0.75 | 1.12 |
| Calmar Ratio | -0.90 | 0.14 |
| Martin Ratio | -1.39 | 0.41 |
| Ulcer Index | 64.40% | 29.77% |
| Daily Std Dev | 99.17% | 81.91% |
| Max Drawdown | -99.10% | -98.45% |
| Current Drawdown | -98.93% | -85.04% |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Correlation
The correlation between DNA and ARDX is 0.32, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Risk-Adjusted Performance
DNA vs. ARDX - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Ginkgo Bioworks Holdings, Inc. (DNA) and Ardelyx, Inc. (ARDX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
DNA vs. ARDX - Dividend Comparison
Neither DNA nor ARDX has paid dividends to shareholders.
Drawdowns
DNA vs. ARDX - Drawdown Comparison
The maximum DNA drawdown since its inception was -99.10%, roughly equal to the maximum ARDX drawdown of -98.45%. Use the drawdown chart below to compare losses from any high point for DNA and ARDX. For additional features, visit the drawdowns tool.
Volatility
DNA vs. ARDX - Volatility Comparison
The current volatility for Ginkgo Bioworks Holdings, Inc. (DNA) is 26.77%, while Ardelyx, Inc. (ARDX) has a volatility of 30.56%. This indicates that DNA experiences smaller price fluctuations and is considered to be less risky than ARDX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
DNA vs. ARDX - Financials Comparison
This section allows you to compare key financial metrics between Ginkgo Bioworks Holdings, Inc. and Ardelyx, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities